Patent details

Basic Information

Publication number:

EP1329458

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP030057863

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Peptides that lower blood glucose levels

French Title of Invention:

Peptides abaissant le taux de glucose sanguin

German Title of Invention:

Peptide, die den Blutzuckergehalt senken

SPC Number:

Dates

Filing date:

12/07/2000

Grant date:

28/03/2012

EP Publication Date:

28/03/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/07/2003

EP B1 Publication Date:

28/03/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/07/2013

Expiration date:

12/07/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/07/2000

 

 

Name:

Zealand Pharma A/S

Address:

Smedeland 36, 2600 Glostrup, Denmark (DK)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

09/05/2012

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Mikkelsen Jens, Damsgaard

Address:

Denmark (DK)

2

Name:

Neve Soren

Address:

Denmark (DK)

3

Name:

Larsen Bjarne, Due

Address:

Denmark (DK)

Priority

1

Priority Number:

143591 P

Priority Date:

12/07/1999

Priority Country:

United States (US)

2

Priority Number:

99610043

Priority Date:

09/08/1999

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07K 14/575;

Filing date	Document type	Number of pages